[go: up one dir, main page]

SE0002835D0 - Method and kit for production of monoclonal antibodies - Google Patents

Method and kit for production of monoclonal antibodies

Info

Publication number
SE0002835D0
SE0002835D0 SE0002835A SE0002835A SE0002835D0 SE 0002835 D0 SE0002835 D0 SE 0002835D0 SE 0002835 A SE0002835 A SE 0002835A SE 0002835 A SE0002835 A SE 0002835A SE 0002835 D0 SE0002835 D0 SE 0002835D0
Authority
SE
Sweden
Prior art keywords
kit
production
monoclonal antibodies
relates
cell
Prior art date
Application number
SE0002835A
Other languages
English (en)
Swedish (sv)
Inventor
Bernhard B Singer
Eva Severinson
Gediminas Greicius
Bjoern Oebrink
Original Assignee
Karolinska Innovations Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations Ab filed Critical Karolinska Innovations Ab
Priority to SE0002835A priority Critical patent/SE0002835D0/xx
Publication of SE0002835D0 publication Critical patent/SE0002835D0/xx
Priority to AU2001280368A priority patent/AU2001280368A1/en
Priority to US10/344,036 priority patent/US20040005321A1/en
Priority to PCT/SE2001/001714 priority patent/WO2002012535A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE0002835A 2000-08-07 2000-08-07 Method and kit for production of monoclonal antibodies SE0002835D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE0002835A SE0002835D0 (sv) 2000-08-07 2000-08-07 Method and kit for production of monoclonal antibodies
AU2001280368A AU2001280368A1 (en) 2000-08-07 2001-08-07 Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotherapy
US10/344,036 US20040005321A1 (en) 2000-08-07 2001-08-07 Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotheraphy
PCT/SE2001/001714 WO2002012535A1 (fr) 2000-08-07 2001-08-07 Utilisation d'anticorps anti-ceacam pour la stimulation de cellules b dans la production d'anticorps monoclonaux ou en immunotherapie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0002835A SE0002835D0 (sv) 2000-08-07 2000-08-07 Method and kit for production of monoclonal antibodies

Publications (1)

Publication Number Publication Date
SE0002835D0 true SE0002835D0 (sv) 2000-08-07

Family

ID=20280635

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0002835A SE0002835D0 (sv) 2000-08-07 2000-08-07 Method and kit for production of monoclonal antibodies

Country Status (4)

Country Link
US (1) US20040005321A1 (fr)
AU (1) AU2001280368A1 (fr)
SE (1) SE0002835D0 (fr)
WO (1) WO2002012535A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114746119A (zh) * 2019-09-27 2022-07-12 詹森生物科技公司 抗-ceacam抗体及其用途

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004053139A1 (fr) * 2002-12-10 2004-06-24 Apollo Life Sciences Limited Procede de production d'anticorps
US8735157B2 (en) 2005-06-09 2014-05-27 Gal Markel CEACAM1 mediated protective immunity
WO2010125571A1 (fr) * 2009-04-30 2010-11-04 Tel Hashomer Medical Research Infrastructure And Services Ltd. Anticorps anti-ceacam1 et leurs procédés d'utilisation
DE102010024636B4 (de) 2010-06-22 2024-04-18 Universität Duisburg-Essen Antikörper, insbesondere für die Diagnostik
WO2013054320A1 (fr) 2011-10-11 2013-04-18 Tel Hashomer Medical Research Infrastructure And Services Ltd. Anticorps dirigés contre la molécule d'adhésion cellulaire associée à l'antigène carcino-embryonnaire (ceacam)
EP2879709B1 (fr) * 2012-07-31 2020-01-08 The Brigham and Women's Hospital, Inc. Modulation de la réponse immunitaire
ES2825080T3 (es) 2014-04-27 2021-05-14 Famewave Ltd Anticuerpos humanizados contra CEACAM1
US11427647B2 (en) 2014-04-27 2022-08-30 Famewave Ltd. Polynucleotides encoding humanized antibodies against CEACAM1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103770T3 (es) * 1990-11-26 1997-10-01 Akzo Nobel Nv Procedimiento de produccion de anticuerpos monoclonales.
JP4843138B2 (ja) * 1998-04-15 2011-12-21 ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド Ｔ細胞阻害性受容体組成物およびその使用
AU6940700A (en) * 1999-08-26 2001-03-19 Amy P. N Skubitz Peptides capable of modulating the function of cd66 (ceacam) family members

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114746119A (zh) * 2019-09-27 2022-07-12 詹森生物科技公司 抗-ceacam抗体及其用途

Also Published As

Publication number Publication date
AU2001280368A1 (en) 2002-02-18
WO2002012535B1 (fr) 2002-07-18
WO2002012535A1 (fr) 2002-02-14
US20040005321A1 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
YU28503A (sh) Humanizovana anti-lt-beta-r antitela
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
BRPI9912227B1 (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
ATE304592T1 (de) Automatisierung im proteinentwurf durch proteinbibliotheken
EP0914155A4 (fr) Anticorps monoclonaux de l'antigene membranaire specifique de la prostate
NZ595450A (en) Antibodies to M-CSF
ATE517340T1 (de) Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren
SI1644484T1 (sl) Avtologne samo-toleranco inducirajoče celice monocitnega izvora in njihova uporaba v farmacevtskihpripravah
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
AU2174002A (en) Method for analyzing proteins
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
DE69934250D1 (de) Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
ZA9710964B (en) Synthetic biepitope compounds which can be used as standards in the biological assays of troponin I
DE59709109D1 (de) Monoklonale antikörper gegen einen komplex aus humanem act und einer serinprotease
PT1127133E (pt) Polipeptido que proporciona permeabilidade celular
DK1171157T3 (da) Anvendelse af glucose-6-phosphat-isomerase og antistoffer derimod til diagnosticering og behandling af arthritis, og test for anti-arthritis-forbindelser
DK1208213T3 (da) Fremgangsmåde til fremstilling af proteiner i værtsceller under anvendelse af chaperoniner
DE59813125D1 (de) Srcr domäne-enthaltendes protein
DE60021409D1 (de) Neurokinin b vorläufer aus menschlicher plazenta
ATE343596T1 (de) Humane monoklonale antikörper gegen inselzellantigen ia-2
DE50008417D1 (de) Verfahren zur bestimmung der avidität von antikörpern
MY142798A (en) Methods for preventing glyconoylation of proteins
PT650523E (pt) Antigene cdw52 recombinante
BR0204612A (pt) Anticorpos monoclonais antinúcleo de hcv